Liquidia (LQDA) Change in Accured Expenses (2020 - 2026)
Liquidia (LQDA) recorded quarterly Change in Accured Expenses of $14.5 million in Q1 2026, down 55.63% quarter-over-quarter from $32.8 million in Q4 2025, and up 401.62% on a YoY basis from $2.9 million in Q1 2025.
Liquidia (LQDA) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Liquidia's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $14.5 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 401.62% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at $73.9 million (up 32649.78% YoY), while the FY2025 annual figure was $54.5 million, up 937.04% from the prior year.
- Change in Accured Expenses was $14.5 million for Q1 2026 at Liquidia, down from $32.8 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $32.8 million in Q4 2025 to a low of -$4.8 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged $4.9 million across 5 years, with a median of $1.8 million in 2023.
- Biggest YoY gain for Change in Accured Expenses was 1913.33% in 2023; the steepest drop was 3781.43% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at $330000.0 in 2022, then surged by 1913.33% to $6.6 million in 2023, then tumbled by 70.38% to $2.0 million in 2024, then soared by 1564.28% to $32.8 million in 2025, then tumbled by 55.63% to $14.5 million in 2026.
- The last three Change in Accured Expenses figures came in at $14.5 million (Q1 2026), $32.8 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 10.02 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 14.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.53 Mn |
| Mar 31, 2026 | 14.53 Mn |
| Dec 31, 2025 | 32.75 Mn |
| Dec 31, 2025 | 32.75 Mn |
| Sep 30, 2025 | 17.92 Mn |
| Sep 30, 2025 | 17.92 Mn |
| Jun 30, 2025 | 8.68 Mn |
| Jun 30, 2025 | 8.68 Mn |
| Mar 31, 2025 | -4.82 Mn |
| Mar 31, 2025 | -4.82 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 3.59 Mn |
| Sep 30, 2024 | 3.59 Mn |
| Jun 30, 2024 | -968,000.00 |
| Jun 30, 2024 | -968,000.00 |
| Mar 31, 2024 | 668,000.00 |
| Mar 31, 2024 | 668,000.00 |
| Dec 31, 2023 | 6.64 Mn |
| Dec 31, 2023 | 6.64 Mn |